Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine

Abstract: Methylphenidate promotes a dose‐dependent behavioral profile that is very comparable to that of amphetamine. Amphetamine increases extracellular norepinephrine and serotonin, in addition to its effects on dopamine, and these latter effects may play a role in the behavioral effects of amphetamine‐like stimulants. To examine further the relative roles of dopamine, norepinephrine, and serotonin in the behavioral response to amphetamine‐like stimulants, we assessed extracellular dopamine and serotonin in caudate putamen and norepinephrine in hippocampus in response to various doses of methylphenidate (10, 20, and 30 mg/kg) that produce stereotyped behaviors, and compared the results with those of a dose of amphetamine (2.5 mg/kg) that produces a level of stereotypies comparable to the intermediate dose of methylphenidate. The methylphenidate‐induced changes in dopamine and its metabolites were consistent with changes induced by other uptake blockers, and the magnitude of the dopamine response for a behaviorally comparable dose was considerably less than that with amphetamine. Likewise, the dose‐dependent increase in norepinephrine in response to methylphenidate was also significantly less than that with amphetamine. However, in contrast to amphetamine, methylphenidate had no effect on extracellular serotonin. These results do not support the hypothesis that a stimulant‐induced increase in serotonin is necessary for the appearance of stereotyped behaviors.

[1]  D. Segal,et al.  Behavioral effects of xylamine-induced depletions of brain norepinephrine: Interaction with amphetamine , 1986, Behavioural Brain Research.

[2]  B. Westerink,et al.  Characterization of In Vivo Dopamine Release as Determined by Brain Microdialysis After Acute and Subchronic Implantations: Methodological Aspects , 1988, Journal of neurochemistry.

[3]  S. Ross.  The central stimulatory action of inhibitors of the dopamine uptake. , 1979, Life sciences.

[4]  M. Kuhar,et al.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.

[5]  W Melega,et al.  Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  R. Rech,et al.  Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze. , 1972, Journal of comparative and physiological psychology.

[7]  H. Fibiger,et al.  In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis , 1990, Synapse.

[8]  D. Segal,et al.  Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine , 1992, Synapse.

[9]  J. Meyer,et al.  Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study , 1991, Brain Research.

[10]  S. Paul,et al.  [3H]Threo‐(±)‐Methylphenidate Binding to 3,4‐Dihydroxyphenylethylamine Uptake Sites in Corpus Striatum: Correlation with the Stimulant Properties of Ritalinic Acid Esters , 1985, Journal of neurochemistry.

[11]  S. Antelman,et al.  Norepinephrine-dopamine interactions and behavior. , 1977, Science.

[12]  D. Segal,et al.  Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  B. Brodie,et al.  A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAIN , 1957, Annals of the New York Academy of Sciences.

[14]  D. Segal.  Differential Effects of Serotonin Depletion on Amphetamine-Induced Locomotion and Stereotypy , 1977 .

[15]  J. B. Justice,et al.  Sampling considerations for on-line microbore liquid chromatography of brain dialysate. , 1986, Analytical chemistry.

[16]  P. H. Andersen.  The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action , 1989 .

[17]  D. Segal.  Differential effects of Para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy , 1976, Brain Research.

[18]  L. Swanson.  The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[19]  G. Rudnick,et al.  Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. , 1995, Molecular pharmacology.

[20]  B. Campbell,et al.  Serotonergic inhibition of catecholamine-induced behavioral arousal. , 1973, Brain research.

[21]  P. H. Andersen.  Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex , 1987, Journal of neurochemistry.

[22]  D. Segal,et al.  Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  L. Parsons,et al.  Serotonin and Dopamine Sensitization in the Nucleus Accumbens, Ventral Tegmental Area, and Dorsal Raphe Nucleus Following Repeated Cocaine Administration , 1993, Journal of neurochemistry.

[24]  B. Cooper,et al.  EVIDENCE FOR INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE ACTIONS OF AMPHETAMINE , 1974, British journal of pharmacology.

[25]  D. Segal,et al.  Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. , 1987, The Journal of pharmacology and experimental therapeutics.

[26]  D. Segal,et al.  Amphetamine and its analogs : psychopharmacology, toxicology, and abuse , 1994 .

[27]  D. Segal,et al.  Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways , 1976, Brain Research.

[28]  D. Segal,et al.  Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment , 1994, Brain Research.

[29]  H. Benveniste,et al.  Determination of Brain Interstitial Concentrations by Microdialysis , 1989, Journal of neurochemistry.

[30]  L. Grant,et al.  Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions. , 1972, Physiology & behavior.

[31]  Ruoyan Chen,et al.  Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. , 1996, Life sciences.

[32]  J. Fowler,et al.  Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. , 1994, European journal of pharmacology.

[33]  U. Ungerstedt,et al.  In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. , 1989, European journal of pharmacology.

[34]  R. Ferris,et al.  A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. , 1972, The Journal of pharmacology and experimental therapeutics.

[35]  D. Segal,et al.  Metabolic and experiential factors in the behavioral response to repeated amphetamine , 1977, Pharmacology Biochemistry and Behavior.

[36]  R. Holman.  Biological effects of central nervous system stimulants. , 1994, Addiction.